-
Biotech gainers: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), RXi Pharmaceuticals Corp (NASDAQ:RXII), Trevena Inc (NASDAQ:TRVN), MediciNova, Inc. (NASDAQ:MNOV)
Anacor Pharmaceuticals (NASDAQ:ANAC) had its price objective hosited by Jefferies Group from $24.00 to $25.00 in a report released on Friday. Jefferies Group currently has a buy rating on the stock. Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) closed at $19.50 in last trading session. Yesterday share price of the company was traded in the range…
-
Biotech Active Movers – VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MediciNova, Inc. (NASDAQ:MNOV)
Vivus Inc. (NASDAQ:VVUS) will test its weight loss drug Qsymia in a pilot program with Aetna Inc. Hartford-based Aetna (NYSE:AET) will incorporate Qsymia into a program that combines it with “lifestyle support for weight loss.” Shares of VIVUS, Inc. (NASDAQ:VVUS) closed at $9.46 in last trading session. Yesterday share price of the company was traded…
-
Worst Biotech Stocks To Watch – AFFY, CYTX, OPXA, MNOV
Affymax, Inc. (NASDAQ:AFFY) is expected to released its fourth quarter earning 2012 on Thursday this week. The company in less than two weeks mortified shareholders after it and along with its licensing partner Takeda Pharmaceuticals declared the voluntary recall of anemia drug Omontys. This would be conference call for Omontys is far more important to…